Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis.

CompletedOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

July 31, 2024

Study Completion Date

July 31, 2024

Conditions
Cerebral Venous Thrombosis
Interventions
DRUG

Methylprednisolone

In the steroid therapy group, patients received standard treatment plus steroid therapy. Steroid therapy protocol is as follows: 500 mg methylprednisolone once a day, intravenous drip for 3 days, then reduced to 80 mg once a day, intravenous drip for 5 days, and changed to oral methylprednisolone/prednisone 1 mg per kilogram body weight, gradually tapered off by a dose of 10 mg per week.

Trial Locations (1)

Unknown

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER

NCT05990894 - Steroid for Treatment of Acute/Subacute Severe Cerebral Venous Thrombosis. | Biotech Hunter | Biotech Hunter